Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001055726-24-000055
Filing Date
2024-12-18
Accepted
2024-12-18 19:01:52
Documents
1
Period of Report
2024-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1734566506.html 4  
1 FORM 4 wk-form4_1734566506.xml 4 6139
  Complete submission text file 0001055726-24-000055.txt   7941
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Issuer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address
Sumner Michael John (Reporting) CIK: 0001936799 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14888 | Film No.: 241560588